These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 8417411)
21. [Obesity and hypertension: from physiopathology to treatment]. Geronooz I; Krzesinski JM Rev Med Liege; 2000 Oct; 55(10):921-8. PubMed ID: 11244800 [TBL] [Abstract][Full Text] [Related]
22. Obesity hypertension in children: a problem of epidemic proportions. Sorof J; Daniels S Hypertension; 2002 Oct; 40(4):441-7. PubMed ID: 12364344 [TBL] [Abstract][Full Text] [Related]
23. [The cardiovascular risk factor in obesity]. Laufs U; Böhm M Dtsch Med Wochenschr; 2000 Mar; 125(9):262-8. PubMed ID: 10742819 [No Abstract] [Full Text] [Related]
24. Mechanisms in obesity-related hypertension: role of insulin and catecholamines. Krieger DR; Landsberg L Am J Hypertens; 1988 Jan; 1(1):84-90. PubMed ID: 3285861 [TBL] [Abstract][Full Text] [Related]
26. Hemodynamics of the male fat distribution pattern. Jern S Blood Press Suppl; 1992; 4():21-8. PubMed ID: 1345331 [TBL] [Abstract][Full Text] [Related]
27. Clustering of cardiovascular disease risk factors among obese schoolchildren: the Taipei Children Heart Study. Chu NF; Rimm EB; Wang DJ; Liou HS; Shieh SM Am J Clin Nutr; 1998 Jun; 67(6):1141-6. PubMed ID: 9625086 [TBL] [Abstract][Full Text] [Related]
28. Insulin resistance, hyperinsulinemia and hypertension. Weidmann P; de Courten M; Böhlen L J Hypertens Suppl; 1993 Dec; 11(5):S27-38. PubMed ID: 8158379 [TBL] [Abstract][Full Text] [Related]
30. Metabolic risk factors and markers of cardiovascular and renal damage in overweight subjects. Bigazzi R; Bianchi S; Batini V; Guzzo D; Campese VM Am J Hypertens; 2006 Apr; 19(4):426-31. PubMed ID: 16580581 [TBL] [Abstract][Full Text] [Related]
31. Molecular basis of obesity and the risk for cardiovascular disease. Soufi M; Sattler AM; Herzum M; Maisch B; Schaefer JR Herz; 2006 May; 31(3):200-6. PubMed ID: 16770555 [TBL] [Abstract][Full Text] [Related]
32. Is it hyperinsulinemia or insulin resistance that is related to hypertension and other metabolic cardiovascular risk factors? Lind L; Lithell H; Pollare T J Hypertens Suppl; 1993 Jun; 11(4):S11-6. PubMed ID: 8377030 [TBL] [Abstract][Full Text] [Related]
33. Preface: Chronic diseases in childhood obesity: risks and benefits of early intervention. Ohio, April 2-3, 2009. Teich S; Michalsky MP Semin Pediatr Surg; 2009 Aug; 18(3):125. PubMed ID: 19573753 [No Abstract] [Full Text] [Related]
34. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy. Chapman MJ; Sposito AC Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759 [TBL] [Abstract][Full Text] [Related]
35. Louis K. Dahl Memorial Lecture. Renal and cardiovascular mechanisms of hypertension in obesity. Hall JE Hypertension; 1994 Mar; 23(3):381-94. PubMed ID: 8125566 [TBL] [Abstract][Full Text] [Related]
36. Obesity and cardiovascular disease. Shaper AG Ciba Found Symp; 1996; 201():90-103; discussion 103-7, 188-93. PubMed ID: 9017276 [TBL] [Abstract][Full Text] [Related]
38. The relationship between insulin resistance and cardiovascular risk factors in overweight/obese non-diabetic Asian adults: the 1992 Singapore National Health Survey. Lim SC; Tan BY; Chew SK; Tan CE Int J Obes Relat Metab Disord; 2002 Nov; 26(11):1511-6. PubMed ID: 12439654 [TBL] [Abstract][Full Text] [Related]
39. Beneficial health effects of modest weight loss. Goldstein DJ Int J Obes Relat Metab Disord; 1992 Jun; 16(6):397-415. PubMed ID: 1322866 [TBL] [Abstract][Full Text] [Related]
40. Epidemiologic and clinical aspects of insulin resistance and hyperinsulinemia. Flack JM; Sowers JR Am J Med; 1991 Jul; 91(1A):11S-21S. PubMed ID: 1867224 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]